08:31 AM EDT, 06/23/2025 (MT Newswires) -- Quanterix ( QTRX ) said Monday that its HD-X Simoa Immunoassay Analyzer received Class 1 Medical Device registration from South Korea's Ministry of Food and Drug Safety, enabling broader access to its biomarker detection platform in the region.

The platform delivers ultrasensitive biomarker detection in blood, serum or plasma, with the ability to quantify proteins that are far lower than the Level of Quantification of traditional measurement platforms.

The company also announced new collaborations with major laboratories and testing centers globally to support the expansion of Alzheimer's disease diagnostics.